Себестоимость Изменить Дата
Abbott USD 5.3B 380M 2026-03
Accuray USD 116.17M 14.63M 2024-12
Align Technology USD 303.5M 60.47M 2026-03
AngioDynamics USD 37.29M 786K 2025-09
Dentsply International USD 453M 65M 2026-03
Dexcom USD 441.6M 25.3M 2026-03
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Fujifilm JPY 550.58B 40.74B 2026-03
Globus Medical USD 263.59M 26.88M 2026-03
Henry Schein USD 2.3B 145M 2026-03
Idexx Laboratories USD 418.08M 14.38M 2026-03
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 232.7M 17.5M 2026-03
Integra LifeSciences USD 178.71M 14.73M 2026-03
Intuitive Surgical USD 940.3M 21.6M 2026-03
Masimo USD 152.8M 12.4M 2026-03
Neogen USD 112.2M 5.81M 2025-12
Orthofix International USD 66.63M 6.4M 2025-12
Phibro Animal Health USD 240.42M 2.58M 2025-12
ResMed USD 551.67M 4.17M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Steris USD 891.3M 50.6M 2026-03
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 240.84M 20.7M 2026-03
Thermo Fisher Scientific USD 6.96B 620M 2026-03
Zoetis USD 672M 71M 2026-03